New RAMP report and Invacare, Respironics and Apria announce latest quarter earnings: A new RAMP report has just been issued by the Power Wheelchair Industry: Here’s the headline: Government Data Refutes CMS Claims that Utilization of Mobility Benefit Is on the Rise – Utilization Sharply Declined Since 2003; No Support for CMS Claims of Increases. [...]
Archive | October, 2006
Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems – Draft Guidance for Industry and FDA Staff
FDA seeks comments on BGMS (essentially diabetic products using fingerstick method) Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems (BGMS) – Draft Guidance for Industry and FDA Staff
Stent Clinical Trial Taxus® and Cypher® in Diabetics
While re-intervention rates at one year were similar between arch rivals Johnson and Johnson and Boston Scientific, this study claims that Taxus® has statistically superior performance in the fast growing diabetic population. Boston Scientific Corporation – TAXUS® Performance Superior to Cypher® in Diabetic Patients in Head-to-Head Study
Rehacare Europe 2006 – And The Winner Is
Reha has now come and gone again and I have decided to choose a winner. Handicare is the winner, and this is the reason. Less than a year after acquiring Movingpeople , Handicare has done a great job of presenting one face to their European customer. Their booth was simple and clearly branded. In addition [...]
Disguised Kickback Scheme In The Homecare Industry- Really?
In the latest HME News there is an interesting, if not curious write-up concerning the Office of Inspector General issuing a (its not clear) warning to an alleged wheelchair manufacturer that “providing dealers (my words) with advertising and reimbursement advice may not be a good idea – allegedly because of the possibility of “kickbacks”.” Well [...]
JANUVIA(TM) (sitagliptin phosphate) is coming soon
JANUVIA(TM) (sitagliptin phosphate) is coming soon If approved, JANUVIA would potentially be the first in a new class of oral medications (DPP-4 inhibitors) that enhances the body’s own ability to lower blood sugar (glucose) when it is elevated.
Feds Warn Of Counterfeit Diabetes Tests
Feds Warn Of Counterfeit Diabetes Tests counterfeit blood glucose test strips reportedly being sold in the United States (consumeraffairs.com)
Medicare – Suppliers Raise Concerns About Scheduled Reduction in Medicare Reimbursements for Power Wheelchairs
The quick read: Medicare reduces reimbursement about 35% November 15 CMS spokesperson Ellen Griffith said “Medicare was paying for the equipment at a much higher rate than what it was being sold for on the market” Cara Bachenheimer — vice president of government affairs for Invacare, the largest U.S. manufacturer of power wheelchairs — said, [...]
Follow @sibaya_com on Twitter
